WAVE Life Sciences Ltd. (NASDAQ:WVE) will hold its 2Q20 earnings conference call with the financial community on 10th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.wavelifesciences.com
Earnings Expectation
WAVE Life Sciences Ltd. is expected to report second quarter earnings results, before market open, on Monday 10th August 2020. Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.97 per share. Looking ahead, the full year loss are expected at $ 3.6 per share on the revenues of $ 38.83 million.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system.
